You are here: Home » News » Market » Text

Inovio Pharmaceuticals Has Reported a Net Loss Attributable to The Company of $6.62m

放大字体  缩小字体 Release date:2016-11-30  Views:56
Core Tip: Inovio Pharmaceuticals has reported a net loss attributable to the company of $6.62m, or $0.05 per share, for the third q

Inovio Pharmaceuticals has reported a net loss attributable to the company of $6.62m, or $0.05 per share, for the third quarter ended 30 September 2012 compared to a net loss attributable to the company of $4.54m, or $0.04 per share, for the third quarter ended 30 September 2011.

Total revenues for third quarter of 2012 were $854,696 compared to $2.64m for the third quarter of 2011.

The company reported a net loss attributable to the company of $19.01m, or $0.14 per share, for the nine months ended 30 September 2012 compared to a net loss attributable to the company of $9.78m, or $0.08 per share, for the nine months ended 30 September 2011.

Total revenue of $2.98m was reported for the first nine months of 2012 compared to $8.16m for the first nine months of 2011.

 
 
[ NewsSearch ]  [ Add to Favorites ]  [ Tell a friend ]  [ Print ]  [ Close the window ]

 
Total0bar [View All]  Related Comments

 
Recommended Graphic
RecommendNews
Click Ranking